Northeast Florida Chapter of AANN

Recognition and Treatment of Infections in ESKD and AKI in Sepsis

CE Information
1.25 contact hours
Completion Time
1 hour, 15 minutes
Available Until
June 1, 2026
Posted By
Sepsis Alliance
Sepsis Alliance Sepsis Alliance
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.

Overview

Specialties
Infection Control / Infectious Disease
Clinical Topics
Infectious Disease

Studies have shown that death from sepsis in end-stage kidney disease (ESKD) patients can be up to 50% higher than that of the general population. Furthermore, acute kidney injury (AKI) is a frequent complication associated with sepsis, and AKI from sepsis carries an increased risk of morbidity and mortality.  

During this special World Kidney Day webinar, presented by Sepsis Alliance, presenters will overview infections and sepsis risk factors, outcomes, hemodialysis access considerations, and treatments for ESKD patients. Participants will also learn about AKI risk factors from sepsis, and review treatments, outcomes, and post-sepsis and AKI recovery. 

Learning Objectives

At the end of the activity, the learner should be able to:

  • Review risk factors and outcomes of sepsis in ESKD; 
  • List hemodialysis access type and management considerations; 
  • Explain peritonitis and sepsis management in peritoneal dialysis patients; 
  • Discuss sepsis and AKI as concomitant risk factors; 
  • Describe sepsis and AKI treatments; 
  • Recall sepsis and AKI outcomes and recovery. 

Speakers

Leslie Wong
Leslie Wong MD, MBA, FACP, FASN

Senior Medical Director of Kidney Services and Nephrology; Chief Kidney Health Officer
Intermountain Healthcare

Leslie Wong, MD, MBA, FACP, FASN, is Intermountain Healthcare's Senior Medical Director of Kidney Services and Nephrology, and Chief Kidney Health Officer. In this capacity, Dr. Wong leads Intermountain’s efforts to deliver nationally recognized, valued-based care with an emphasis on reducing the incidence of kidney failure and improving the kidney health of communities across the Mountain West region of the United States. Dr. Wong came to Intermountain from dual roles as Chief Medical Officer of Nephrology Care Alliance, a division of DaVita Inc., and Associate Medical Director of Cleveland Clinic's Medicare Accountable Care Organization. He is a seasoned nephrologist who has served as Cleveland Clinic's Vice-Chairman of Nephrology and Hypertension with an emphasis on clinical transformation, as the Director of the Center for Dialysis, and as an associate professor of medicine at Case Western Reserve University. Dr. Wong is a graduate of the University of Texas Southwestern Medical School. He completed his residency and fellowship training at the University of North Carolina, where he was Chief Resident. He started his career in Seattle, where he was Medical Director of Peritoneal Dialysis at Northwest Kidney Centers. Following this work, he became Satellite Healthcare's Vice President of Clinical Affairs, leading quality and medical director education at that institution. He also served on the faculty at Stanford University. Professionally, he is a nationally recognized nephrology educator and speaker. He is a past member of the American Society of Nephrology (ASN) Dialysis Advisory Group and Chair of Quality, Assessment, Improvement, and Education for Nephrologists Transforming Dialysis Safety (NTDS). Dr. Wong currently participates in the ASN Diabetic Kidney Collaborative and serves on the Excellence in Patient Care (EPC) Committee, helping to guide ASN’s clinical initiatives.

Anitha Vijayan
Anitha Vijayan MD, FASN

Associate Medical Director, Kidney Services

Dr. Anitha Vijayan received her medical degree from the University of the West Indies in 1990. She completed her residency in Internal Medicine at St. Luke’s hospital in Chesterfield, MO and her Nephrology fellowship at Washington University. Dr. Vijayan then joined the Division of Nephrology at Washington University in St. Louis as an instructor in 1999 and promoted to Professor of Medicine in 2012. Dr. Vijayan currently serves as Medical Director of Acute Dialysis Services at Barnes-Jewish Hospital, the premier teaching institution of the university. Her clinical expertise and research has been primarily dedicated to improving outcomes in patients with acute kidney injury. She has published widely in the area of biomarkers for early diagnosis and renal replacement therapy in AKI. In addition to her expertise in AKI, Dr. Vijayan has also been involved in infection prevention and currently chairs a workgroup as part of the ASN-NTDS committee which is focused on reducing infections in hemodialysis patients. She holds several administrative roles at the university and the hospital, including being a member of the Medical School Admissions Committee, Faculty Practice Plan and the Pharmacy and Therapeutics Committee. She is also a member of American Society of Nephrology and National Kidney Foundation.

CE Information

This activity offers 1.25 contact hours to attendees.

Accredited by California Board of Registered Nursing.

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.

Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.


Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Log in and start activity